This module enables investors to look at Bharat Immunologicals various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as , but also many exotic indicators such as . This module is a perfect complement to use when analyzing Bharat Immunologicals Valuation or Volatility. It can also complement various Bharat Immunologicals Technical models. Check also Trending Equities.
Profit Margin AnalysisProfit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
About Profit MarginIn a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.Compare to competition
Based on latest financial disclosure Bharat Immunologicals Biologicals Corp Ltd has Profit Margin of -4.18%. This is much lower than that of the sector, and significantly lower than that of Profit Margin industry, The Profit Margin for all stocks is over 1000% higher than the company.
Bharat Immunologicals Fundamental Drivers Relationships
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
|Hide View All Next||Launch Companies Directory|
|Return On Asset||(1.69) %|
|Profit Margin||(4.18) %|
|Operating Margin||(5.13) %|
|Current Valuation||862.5 M|
|Shares Outstanding||43.18 M|
|Price to Earning||(28.02) times|
|Price to Book||2.50 times|
|Price to Sales||0.66 times|
|Gross Profit||119 M|
|Net Income||(53.46 M)|
|Cash and Equivalents||152.27 M|
|Cash per Share||3.55 times|
|Total Debt||177.56 M|
|Debt to Equity||0.50 times|
|Current Ratio||1.69 times|
|Earnings Per Share||(1.24) times|
|Market Capitalization||1.5 B|